KCNA2 抗体
(Potassium Voltage-Gated Channel, Shaker-Related Subfamily, Member 2 (KCNA2))
Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, members of which allow nerve cells to efficiently repolarize following an action potential. The coding region of this gene is intronless, and the gene is clustered with genes KCNA3 and KCNA10 on chromosome 1. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| KCNA2 抗体 (1st Extracellular Loop) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (APC) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (Biotin) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (HRP) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (FITC) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (Fluoro550) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (Fluoro594) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (Cy3) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (Fluoro488) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (Fluoro647) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) (PE) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) | 大鼠 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) | 人 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) (FL490) | 人 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) (FL550) | 人 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) (FL594) | 人 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) (FL650) | 人 | 小鼠 Monoclonal |
|
|
|
| KCNA2 抗体 (C-Term, Cytosolic) | 大鼠 | 小鼠 Monoclonal |
|
|
Primary Antibody
- M (Molecule: 有验证图片)
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IC (Immunochromatography: 所列应用)
- LCI (Live Cell Imaging: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- 1st Extracellular Loop, AA 189-201
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term, AA 450-479
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IP (Immunoprecipitation: 所列应用)
KO 验证
- 质量等级
- KO Validated
- 适用
- 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- K14-16
- 标记
- unconjugated
- 抗体亚型
- IgG2b
- 抗原表位
- AA 428-499, C-Term, Cytosolic
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- L76-36
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 428-499, C-Term, Cytosolic
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
KO 验证
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- L76-36
- 标记
- FL490
- 抗体亚型
- IgG2a
- 抗原表位
- AA 428-499, C-Term, Cytosolic
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
KO 验证
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- L76-36
- 标记
- FL550
- 抗体亚型
- IgG2a
- 抗原表位
- AA 428-499, C-Term, Cytosolic
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
KO 验证
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- L76-36
- 标记
- FL594
- 抗体亚型
- IgG2a
- 抗原表位
- AA 428-499, C-Term, Cytosolic
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
KO 验证
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- L76-36
- 标记
- FL650
- 抗体亚型
- IgG2a
- 抗原表位
- AA 428-499, C-Term, Cytosolic
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- K14-16
- 标记
- unconjugated
- 抗体亚型
- IgG2b
- 抗原表位
- AA 428-499, C-Term, Cytosolic
Latest Publications for our KCNA2 抗体
: "Identification of a molecular locus for normalizing dysregulated GABA release from interneurons in the Fragile X brain." in: Molecular psychiatry, (2018) (PubMed).
: "Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy." in: Nature medicine, Vol. 21, Issue 1, pp. 19-26, (2015) (PubMed).
: "Use-dependent activation of neuronal Kv1.2 channel complexes." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 35, Issue 8, pp. 3515-24, (2015) (PubMed).
: "De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. ..." in: Nature genetics, Vol. 47, Issue 4, pp. 393-9, (2015) (PubMed).
: "Sialylation regulates brain structure and function." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 29, Issue 7, pp. 3040-53, (2015) (PubMed).
: "Human Neuroma-in-Continuity Contains Focal Deficits in Myelination." in: Journal of neuropathology and experimental neurology, Vol. 74, Issue 9, pp. 901-911, (2015) (PubMed).
: "Selective down-regulation of KV2.1 function contributes to enhanced arterial tone during diabetes." in: The Journal of biological chemistry, Vol. 290, Issue 12, pp. 7918-29, (2015) (PubMed).
: "BK Channels Localize to the Paranodal Junction and Regulate Action Potentials in Myelinated Axons of Cerebellar Purkinje Cells." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 35, Issue 18, pp. 7082-94, (2015) (PubMed).
: "Singular localization of sodium channel β4 subunit in unmyelinated fibres and its role in the striatum." in: Nature communications, Vol. 5, pp. 5525, (2014) (PubMed).
: "Ankyrin-G directly binds to kinesin-1 to transport voltage-gated Na+ channels into axons." in: Developmental cell, Vol. 28, Issue 2, pp. 117-31, (2014) (PubMed).
: "Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy." in: Nature medicine, Vol. 21, Issue 1, pp. 19-26, (2015) (PubMed).
: "Use-dependent activation of neuronal Kv1.2 channel complexes." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 35, Issue 8, pp. 3515-24, (2015) (PubMed).
: "De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. ..." in: Nature genetics, Vol. 47, Issue 4, pp. 393-9, (2015) (PubMed).
: "Sialylation regulates brain structure and function." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 29, Issue 7, pp. 3040-53, (2015) (PubMed).
: "Human Neuroma-in-Continuity Contains Focal Deficits in Myelination." in: Journal of neuropathology and experimental neurology, Vol. 74, Issue 9, pp. 901-911, (2015) (PubMed).
: "Selective down-regulation of KV2.1 function contributes to enhanced arterial tone during diabetes." in: The Journal of biological chemistry, Vol. 290, Issue 12, pp. 7918-29, (2015) (PubMed).
: "BK Channels Localize to the Paranodal Junction and Regulate Action Potentials in Myelinated Axons of Cerebellar Purkinje Cells." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 35, Issue 18, pp. 7082-94, (2015) (PubMed).
: "Singular localization of sodium channel β4 subunit in unmyelinated fibres and its role in the striatum." in: Nature communications, Vol. 5, pp. 5525, (2014) (PubMed).
: "Ankyrin-G directly binds to kinesin-1 to transport voltage-gated Na+ channels into axons." in: Developmental cell, Vol. 28, Issue 2, pp. 117-31, (2014) (PubMed).
Aliases for KCNA2 抗体
potassium voltage-gated channel subfamily A member 2 (KCNA2) 抗体potassium channel, voltage gated shaker related subfamily A, member 1 (kcna1) 抗体
potassium voltage-gated channel, shaker-related subfamily, member 2 (Kcna2) 抗体
potassium voltage-gated channel subfamily A member 2 (Kcna2) 抗体
potassium voltage-gated channel subfamily A member 2 (LOC100537815) 抗体
potassium channel, voltage gated shaker related subfamily A, member 2 S homeolog (kcna2.S) 抗体
Akr6a4 抗体
BK2 抗体
ENSMUSG00000074335 抗体
Gm10672 抗体
HBK5 抗体
HK4 抗体
HUKIV 抗体
k(v)1.2 抗体
Kca1-2 抗体
KCNA2 抗体
kcna2 抗体
kcna2-a 抗体
KV1.2 抗体
Kv1.2 抗体
kv1.2 抗体
Mk-2 抗体
MK2 抗体
NGK1 抗体
RBK2 抗体
XSha2 抗体
您还需要查找其他产品吗？
You are here:
